Clinical Report: Elevated PFAS Linked to Changes in Blood Lipids

Overview

This study identifies a significant association between elevated levels of PFAS in human serum and alterations in specific lipid species. The findings suggest that PFAS exposure may influence lipid metabolism, particularly in individuals with higher concentrations of these substances.

Background

Per- and polyfluoroalkyl substances (PFAS) are widespread environmental contaminants linked to various health issues, including dyslipidemia. Understanding the relationship between PFAS exposure and lipid changes is crucial for developing effective clinical guidelines and preventive measures, especially for populations at risk due to occupational or environmental exposure.

Data Highlights

Key Findings

• 34 participants had Σ7 PFAS levels exceeding 20 ng/mL, linked to increased dyslipidemia risk.
• 25 lipid species showed significant differences between exposure groups, with 24 elevated in the higher PFAS group.
• Triglycerides and phosphatidylethanolamines accounted for over 60% of elevated lipids in the higher-exposure group.
• Specific triglyceride species, such as TG (60:13), were strongly associated with PFAS levels.
• PFNA, PFOA, and PFDA exhibited numerous positive correlations with triglycerides and sphingomyelins.

Clinical Implications

Clinicians should consider PFAS exposure as a potential factor in lipid abnormalities when assessing patients, particularly those with known exposure histories. Routine lipid screening may be warranted for individuals with elevated PFAS levels to facilitate early intervention and management of dyslipidemia.

Conclusion

The study underscores the need for further research to elucidate the biological mechanisms linking PFAS exposure to lipid metabolic changes. Enhanced understanding may inform clinical practices and guidelines regarding PFAS-related health risks.

References

1. The National Academies Press, Guidance on PFAS Exposure, Testing, and Clinical Follow-Up, 2024
2. Global Serum Per- and Polyfluoroalkyl Substances Exposures and Their Correlation with Lipids: A Systematic Review and Meta-Analysis, PubMed, 2025
3. Archives of Toxicology, Role of Per- and Polyfluoroalkyl Substances in Cancer Development, 2022
4. Archives of Toxicology, Effects of Perfluorooctanoic Acid (PFOA), Perfluorooctane Sulfonic Acid (PFOS), and Perfluorononanoic Acid (PFNA) on Triglyceride Levels, 2020
5. The Analytical Scientist, Low-Dose PFAS Exposure Alters Cellular Metabolism, 2026
6. Archives of Toxicology — Effects of perfluoroalkyl substances (PFAS) and their combinations on lipid metabolism in differentiated HepaRG cells as a human hepatocyte model
7. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up | The National Academies Press
8. Global Serum Per- and Polyfluoroalkyl Substances Exposures and Their Correlation with Lipids: A Systematic Review and Meta-Analysis - PubMed
9. Effect of Plasma and Blood Donations on Levels of Perfluoroalkyl and Polyfluoroalkyl Substances in Firefighters in Australia: A Randomized Clinical Trial | Environmental Health | JAMA Network Open | JAMA Network